Bacteriology of Aspiration Pneumonia: The Lung Microbiome and the Changing Microbial Etiology

Semin Respir Crit Care Med
DOI: 10.1055/s-0044-1792111

Francois Fadell

1   VA Western New York Healthcare System, Research and Development, Buffalo, New York

2   Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University at Buffalo, Buffalo, New York

,

Ranime Saliba

1   VA Western New York Healthcare System, Research and Development, Buffalo, New York

2   Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University at Buffalo, Buffalo, New York

,

Ali A. El-Solh

1   VA Western New York Healthcare System, Research and Development, Buffalo, New York

2   Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University at Buffalo, Buffalo, New York

3   Department of Anesthesiology, Jacobs School of Medicine, University at Buffalo, Buffalo, New York

4   Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, New York

› Author Affiliations Funding The study was supported in part by a grant from the U.S. Department of Veterans Affairs (AES IO1CX 001656).
  SFX Search  Buy Article Permissions and Reprints Abstract

Aspiration pneumonia refers to the process of alveolar inflammation induced by the inhalation of oropharyngeal secretions into the lower respiratory tract. Predisposing factors comprise swallowing dysfunction, impaired cough reflex, and degenerative neurological diseases. Accumulating evidence projects a fading contribution of anaerobic bacteria in aspiration pneumonia at the expense of Gram-negative bacilli, with Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa, becoming the predominant organisms recovered from respiratory specimens. Aspiration of oropharyngeal secretions colonized with respiratory pathogens induces a profound disequilibrium of the lung microbiota resulting in a state of dysbiosis. Understanding this complex temporal variability between microbiome–host associations was only made possible with the introduction of metagenomic sequencing. In this narrative review, we summarize existing knowledge and elaborate on the evolving microbiology of aspiration pneumonia including the link between oral microbiome and pulmonary aspiration. We also highlight the progress and challenges in instituting microbiome-targeted strategies for preventing and treating the sequelae of aspiration pneumonia.

Keywords aspiration pneumonia - microbiology - microbiome - diagnostic modalities Note

The contents of this paper do not represent the views of the Department of Veterans Affairs or the U.S. Government.

Publication History

Article published online:
13 November 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
References 1 Mendelson CL. The aspiration of stomach contents into the lungs during obstetric anesthesia. Am J Obstet Gynecol 1946; 52: 191-205 2 Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995; 152 (6 Pt 1): 1818-1824 3 Bynum LJ, Pierce AK. Pulmonary aspiration of gastric contents. Am Rev Respir Dis 1976; 114 (06) 1129-1136 4 Mandell LA, Niederman MS. Aspiration pneumonia. N Engl J Med 2019; 380 (07) 651-663 5 Goodwin RS. Prevention of aspiration pneumonia: a research-based protocol. Dimens Crit Care Nurs 1996; 15 (02) 58-71 , quiz 72 6 Reza Shariatzadeh M, Huang JQ, Marrie TJ. Differences in the features of aspiration pneumonia according to site of acquisition: community or continuing care facility. J Am Geriatr Soc 2006; 54 (02) 296-302 7 Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 1989; 11 (04) 586-599 8 Lanspa MJ, Jones BE, Brown SM, Dean NC. Mortality, morbidity, and disease severity of patients with aspiration pneumonia. J Hosp Med 2013; 8 (02) 83-90 9 Teramoto S, Yoshida K, Hizawa N. Update on the pathogenesis and management of pneumonia in the elderly-roles of aspiration pneumonia. Respir Investig 2015; 53 (05) 178-184 10 Kalil AC, Metersky ML, Klompas M. et al. Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016; 63 (05) 575-582 11 Almirall J, Rofes L, Serra-Prat M. et al. Oropharyngeal dysphagia is a risk factor for community-acquired pneumonia in the elderly. Eur Respir J 2013; 41 (04) 923-928 12 Kikuchi R, Watabe N, Konno T, Mishina N, Sekizawa K, Sasaki H. High incidence of silent aspiration in elderly patients with community-acquired pneumonia. Am J Respir Crit Care Med 1994; 150 (01) 251-253 13 Loeb M, McGeer A, McArthur M, Walter S, Simor AE. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999; 159 (17) 2058-2064 14 Langmore SE, Terpenning MS, Schork A. et al. Predictors of aspiration pneumonia: how important is dysphagia?. Dysphagia 1998; 13 (02) 69-81 15 Terré-Boliart R, Orient-López F, Guevara-Espinosa D, Ramón-Rona S, Bernabeu-Guitart M, Clavé-Civit P. [Oropharyngeal dysphagia in patients with multiple sclerosis]. Rev Neurol 2004; 39 (08) 707-710 16 DeToledo JC, Lowe MR, Gonzalez J, Haddad H. Risk of aspiration pneumonia after an epileptic seizure: a retrospective analysis of 1634 adult patients. Epilepsy Behav 2004; 5 (04) 593-595 17 Foocharoen C, Siriphannon Y, Mahakkanukrauh A, Suwannaroj S, Nanagara R. Incidence rate and causes of infection in Thai systemic sclerosis patients. Int J Rheum Dis 2012; 15 (03) 277-283 18 Levin K, Colon A, DiPalma J, Fitzpatrick S. Using the radionuclide salivagram to detect pulmonary aspiration and esophageal dysmotility. Clin Nucl Med 1993; 18 (02) 110-114 19 Adnet F, Baud F. Relation between Glasgow Coma Scale and aspiration pneumonia. Lancet 1996; 348 (9020): 123-124 20 Mizock BA. Risk of aspiration in patients on enteral nutrition: frequency, relevance, relation to pneumonia, risk factors, and strategies for risk reduction. Curr Gastroenterol Rep 2007; 9 (04) 338-344 21 Gomes GF, Pisani JC, Macedo ED, Campos AC. The nasogastric feeding tube as a risk factor for aspiration and aspiration pneumonia. Curr Opin Clin Nutr Metab Care 2003; 6 (03) 327-333 22 Fox KA, Mularski RA, Sarfati MR. et al. Aspiration pneumonia following surgically placed feeding tubes. Am J Surg 1995; 170 (06) 564-566 , discussion 566–567 23 El Solh AA, Brewer T, Okada M, Bashir O, Gough M. Indicators of recurrent hospitalization for pneumonia in the elderly. J Am Geriatr Soc 2004; 52 (12) 2010-2015 24 Quagliarello V, Ginter S, Han L, Van Ness P, Allore H, Tinetti M. Modifiable risk factors for nursing home-acquired pneumonia. Clin Infect Dis 2005; 40 (01) 1-6 25 Hata R, Noguchi S, Kawanami T. et al. Poor oral hygiene is associated with the detection of obligate anaerobes in pneumonia. J Periodontol 2020; 91 (01) 65-73 26 Mira A, Simon-Soro A, Curtis MA. Role of microbial communities in the pathogenesis of periodontal diseases and caries. J Clin Periodontol 2017; 44 (Suppl. 18) S23-S38 27 Winning L, Lundy FT, Blackwood B, McAuley DF, El Karim I. Oral health care for the critically ill: a narrative review. Crit Care 2021; 25 (01) 353 28 Kikutani T, Tamura F, Tashiro H, Yoshida M, Konishi K, Hamada R. Relationship between oral bacteria count and pneumonia onset in elderly nursing home residents. Geriatr Gerontol Int 2015; 15 (04) 417-421 29 Bächli P, Baars S, Simmler A, Zbinden R, Schulthess B. Impact of MALDI-TOF MS identification on anaerobic species and genus diversity in routine diagnostics. Anaerobe 2022; 75: 102554 30 Zarco MF, Vess TJ, Ginsburg GS. The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis 2012; 18 (02) 109-120 31 Overmann J, Abt B, Sikorski J. Present and future of culturing bacteria. Annu Rev Microbiol 2017; 71: 711-730 32 Tortuyaux R, Voisin B, Cordonnier C, Nseir S. Could polymerase chain reaction-based methods differentiate pneumonitis from bacterial aspiration pneumonia?. Crit Care Med 2018; 46 (01) e96-e97 33 Darie AM, Khanna N, Jahn K. et al. Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial. Lancet Respir Med 2022; 10 (09) 877-887 34 Tavares DA, Handem S, Carvalho RJ. et al. Identification of Streptococcus pneumoniae by a real-time PCR assay targeting SP2020. Sci Rep 2019; 9 (01) 3285 35 Carney SM, Clemente JC, Cox MJ. et al. Methods in lung microbiome research. Am J Respir Cell Mol Biol 2020; 62 (03) 283-299 36 Lane DJ, Pace B, Olsen GJ, Stahl DA, Sogin ML, Pace NR. Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses. Proc Natl Acad Sci U S A 1985; 82 (20) 6955-6959 37 Zhang Y, Ji P, Wang J, Zhao F. RiboFR-Seq: a novel approach to linking 16S rRNA amplicon profiles to metagenomes. Nucleic Acids Res 2016; 44 (10) e99 38 Whiteside SA, McGinniss JE, Collman RG. The lung microbiome: progress and promise. J Clin Invest 2021; 131 (15) 131 39 Johnson JS, Spakowicz DJ, Hong BY. et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat Commun 2019; 10 (01) 5029 40 Wilson MR, Naccache SN, Samayoa E. et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med 2014; 370 (25) 2408-2417 41 Mac Aogáin M, Lau KJX, Cai Z. et al. Metagenomics reveals a core macrolide resistome related to microbiota in chronic respiratory disease. Am J Respir Crit Care Med 2020; 202 (03) 433-447 42 Millares L, Pérez-Brocal V, Ferrari R. et al. Functional metagenomics of the bronchial microbiome in COPD. PLoS One 2015; 10 (12) e0144448 43 Simner PJ, Miller S, Carroll KC. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clin Infect Dis 2018; 66 (05) 778-788 44 Schmieder R, Edwards R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 2011; 27 (06) 863-864 45 Hasan MR, Rawat A, Tang P. et al. Depletion of human DNA in spiked clinical specimens for improvement of sensitivity of pathogen detection by next-generation sequencing. J Clin Microbiol 2016; 54 (04) 919-927 46 Pendleton KM, Erb-Downward JR, Bao Y. et al. Rapid pathogen identification in bacterial pneumonia using real-time metagenomics. Am J Respir Crit Care Med 2017; 196 (12) 1610-1612 47 Zhou H, Larkin PMK, Zhao D. et al. Clinical impact of metagenomic next-generation sequencing of bronchoalveolar lavage in the diagnosis and management of pneumonia: a multicenter prospective observational study. J Mol Diagn 2021; 23 (10) 1259-1268 48 Xu H, Zhang R, Zhang X, Cheng Y, Lv L, Lin L. Microbiological profile of patients with aspiration pneumonia identified by combined detection methods. Infect Drug Resist 2024; 17: 2077-2088 49 Marchesi JR, Ravel J. The vocabulary of microbiome research: a proposal. Microbiome 2015; 3: 31 50 Charlson ES, Bittinger K, Haas AR. et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 2011; 184 (08) 957-963 51 Dickson RP, Erb-Downward JR, Freeman CM. et al. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann Am Thorac Soc 2015; 12 (06) 821-830 52 Sommariva M, Le Noci V, Bianchi F. et al. The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy. Cell Mol Life Sci 2020; 77 (14) 2739-2749 53 Alsayed AR, Abed A, Khader HA. et al. Molecular accounting and profiling of human respiratory microbial communities: toward precision medicine by targeting the respiratory microbiome for disease diagnosis and treatment. Int J Mol Sci 2023; 24 (04) 24 54 Dickson RP, Erb-Downward JR, Freeman CM. et al. Bacterial topography of the healthy human lower respiratory tract. MBio 2017; 8 (01) 8 55 Goeteyn E, Grassi L, Van den Bossche S. et al. Commensal bacteria of the lung microbiota synergistically inhibit inflammation in a three-dimensional epithelial cell model. Front Immunol 2023; 14: 1176044 56 Wang L, He Y, Li H, Ai Q, Yu J. The microbiota protects against Pseudomonas aeruginosa pneumonia via γδ T cell-neutrophil axis in mice. Microbes Infect 2020; 22 (08) 294-302 57 Whiteson KL, Bailey B, Bergkessel M. et al. The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography. Am J Respir Crit Care Med 2014; 189 (11) 1309-1315 58 Pettigrew MM, Tanner W, Harris AD. The lung microbiome and pneumonia. J Infect Dis 2021; 223 (12, Suppl 2): S241-S245 59 Dickson RP, Erb-Downward JR, Huffnagle GB. Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Respir Med 2014; 2 (03) 238-246 60 Belizário J, Garay-Malpartida M, Faintuch J. Lung microbiome and origins of the respiratory diseases. Curr Res Immunol 2023; 4: 100065 61 Lloyd CM, Marsland BJ. Lung homeostasis: influence of age, microbes, and the immune system. Immunity 2017; 46 (04) 549-561 62 Wu BG, Sulaiman I, Tsay JJ. et al. Episodic aspiration with oral commensals induces a MyD88-dependent, pulmonary T-helper cell type 17 response that mitigates susceptibility to Streptococcus pneumoniae . Am J Respir Crit Care Med 2021; 203 (09) 1099-1111 63 Horn KJ, Schopper MA, Drigot ZG, Clark SE. Airway Prevotella promote TLR2-dependent neutrophil activation and rapid clearance of Streptococcus pneumoniae from the lung. Nat Commun 2022; 13 (01) 3321 64 Natalini JG, Singh S, Segal LN. The dynamic lung microbiome in health and disease. Nat Rev Microbiol 2023; 21 (04) 222-235 65 Dickson RP, Singer BH, Newstead MW. et al. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat Microbiol 2016; 1 (10) 16113 66 Barfod KK, Vrankx K, Mirsepasi-Lauridsen HC. et al. The murine lung microbiome changes during lung inflammation and intranasal vancomycin treatment. Open Microbiol J 2015; 9: 167-179 67 Bartlett JG, Gorbach SL, Finegold SM. The bacteriology of aspiration pneumonia. Am J Med 1974; 56 (02) 202-207 68 Cesar L, Gonzalez C, Calia FM. Bacteriologic flora of aspiration-induced pulmonary infections. Arch Intern Med 1975; 135 (05) 711-714 69 Lorber B, Swenson RM. Bacteriology of aspiration pneumonia. A prospective study of community- and hospital-acquired cases. Ann Intern Med 1974; 81 (03) 329-331 70 Bartlett JG, Gorbach SL. The triple threat of aspiration pneumonia. Chest 1975; 68 (04) 560-566 71 Brook I, Finegold SM. Bacteriology of aspiration pneumonia in children. Pediatrics 1980; 65 (06) 1115-1120 72 Hayashi M, Iwasaki T, Yamazaki Y. et al. Clinical features and outcomes of aspiration pneumonia compared with non-aspiration pneumonia: a retrospective cohort study. J Infect Chemother 2014; 20 (07) 436-442 73 Suzuki J, Ikeda R, Kato K. et al. Characteristics of aspiration pneumonia patients in acute care hospitals: a multicenter, retrospective survey in Northern Japan. PLoS One 2021; 16 (07) e0254261 74 El-Solh AA, Pietrantoni C, Bhat A. et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med 2003; 167 (12) 1650-1654 75 Tokuyasu H, Harada T, Watanabe E. et al. Effectiveness of meropenem for the treatment of aspiration pneumonia in elderly patients. Intern Med 2009; 48 (03) 129-135 76 El-Solh AA, Pietrantoni C, Bhat A. et al. Colonization of dental plaques: a reservoir of respiratory pathogens for hospital-acquired pneumonia in institutionalized elders. Chest 2004; 126 (05) 1575-1582 77 Fourrier F, Duvivier B, Boutigny H, Roussel-Delvallez M, Chopin C. Colonization of dental plaque: a source of nosocomial infections in intensive care unit patients. Crit Care Med 1998; 26 (02) 301-308 78 Ewan VC, Sails AD, Walls AW, Rushton S, Newton JL. Dental and microbiological risk factors for hospital-acquired pneumonia in non-ventilated older patients. PLoS One 2015; 10 (04) e0123622 79 Cilloniz C, Martin-Loeches I, Garcia-Vidal C, San Jose A, Torres A. Microbial etiology of pneumonia: epidemiology, diagnosis and resistance patterns. Int J Mol Sci 2016; 17 (12) 17 80 Mori H, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M. Oral care reduces incidence of ventilator-associated pneumonia in ICU populations. Intensive Care Med 2006; 32 (02) 230-236 81 Otsuji K, Fukuda K, Ogawa M, Fujino Y, Kamochi M, Saito M. Dynamics of microbiota during mechanical ventilation in aspiration pneumonia. BMC Pulm Med 2019; 19 (01) 260 82 Roquilly A, Marret E, Abraham E, Asehnoune K. Pneumonia prevention to decrease mortality in intensive care unit: a systematic review and meta-analysis. Clin Infect Dis 2015; 60 (01) 64-75 83 Roquilly A, Torres A, Villadangos JA. et al. Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia. Lancet Respir Med 2019; 7 (08) 710-720 84 Cheema HA, Shahid A, Ayyan M. et al. Probiotics for the prevention of ventilator-associated pneumonia: an updated systematic review and meta-analysis of randomised controlled trials. Nutrients 2022; 14 (08) 14 85 Zhao J, Li LQ, Chen CY, Zhang GS, Cui W, Tian BP. Do probiotics help prevent ventilator-associated pneumonia in critically ill patients? A systematic review with meta-analysis. ERJ Open Res 2021; 7 (01) 7
 

留言 (0)

沒有登入
gif